Swiss Re introduces guidance for underwriters on repurposed longevity drugs
Reinsurance News - Aug 12, 2025
Swiss Re’s August 2025 Life Guide has introduced guidance for underwriters on how to assess life insurance applicants who show signs of using repurposed longevity drugs, an emerging trend among health-conscious individuals. The update provides new guidance on medications like metformin and rap...
Recommended Articles
Posted: Aug 29, 2025
Lin Mun, an executive with over 21 years of extensive experience in the insurance and reinsurance in...
Posted: Aug 29, 2025
Asian reinsurers are actively expanding to mature overseas markets to diversify their portfolios and...
Posted: Aug 29, 2025
ACORD, the global standards-setting body for the insurance industry, has announced the launch of the...